Your browser doesn't support javascript.
loading
Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents.
Singh, Balraj; Shamsnia, Anna; Raythatha, Milan R; Milligan, Ryan D; Cady, Amanda M; Madan, Simran; Lucci, Anthony.
Afiliação
  • Singh B; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Shamsnia A; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Raythatha MR; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Milligan RD; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Cady AM; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Madan S; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Lucci A; Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
PLoS One ; 9(10): e109487, 2014.
Article em En | MEDLINE | ID: mdl-25279830

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adaptação Fisiológica / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Transição Epitelial-Mesenquimal / Neoplasias de Mama Triplo Negativas / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adaptação Fisiológica / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Transição Epitelial-Mesenquimal / Neoplasias de Mama Triplo Negativas / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article